Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Eagan

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Mayo Clinic Proceedings|September 1, 1984
Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapyM P Davis, R T Eagan, L H Weiland, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomasJ H Edmonson, S Frytak, L Letendre, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Combination chemotherapy and radiation therapy for small cell carcinoma of the lungL H Maurer, M Tulloh, R T Eagan, et al.
Cancer Investigation|January 1, 1988
Treatment of "limited" stage III non-small cell carcinoma of the lungS Frytak, R T Eagan, K Sawamura, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|July 1, 1976
ICRF-159 versus polychemotherapy in non-small cell lung cancerR T Eagan, D T Carr, D T Coles, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer Treatment Reports|July 1, 1976
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancerR T Eagan, D T Carr, S Frytak, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Mayo Clinic Proceedings|September 1, 1984
Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapyM P Davis, R T Eagan, L H Weiland, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomasJ H Edmonson, S Frytak, L Letendre, et al.
Cancer Chemotherapy Reports. Part 3|March 1, 1973
Combination chemotherapy and radiation therapy for small cell carcinoma of the lungL H Maurer, M Tulloh, R T Eagan, et al.
Cancer Investigation|January 1, 1988
Treatment of "limited" stage III non-small cell carcinoma of the lungS Frytak, R T Eagan, K Sawamura, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|July 1, 1976
ICRF-159 versus polychemotherapy in non-small cell lung cancerR T Eagan, D T Carr, D T Coles, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer Treatment Reports|July 1, 1976
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancerR T Eagan, D T Carr, S Frytak, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Pageof 11